Annual D&A
$2.22 M
+$547.70 K+32.73%
31 December 2023
Summary:
Kiromic BioPharma annual depreciation & amortization is currently $2.22 million, with the most recent change of +$547.70 thousand (+32.73%) on 31 December 2023. During the last 3 years, it has risen by +$2.02 million (+1010.55%). KRBP annual D&A is now at all-time high.KRBP Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$552.00 K
-$5000.00-0.90%
30 September 2024
Summary:
Kiromic BioPharma quarterly depreciation & amortization is currently $552.00 thousand, with the most recent change of -$5000.00 (-0.90%) on 30 September 2024. Over the past year, it has dropped by -$9000.00 (-1.60%). KRBP quarterly D&A is now -1.60% below its all-time high of $561.00 thousand, reached on 30 September 2023.KRBP Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$2.22 M
-$9000.00-0.40%
30 September 2024
Summary:
Kiromic BioPharma TTM depreciation & amortization is currently $2.22 million, with the most recent change of -$9000.00 (-0.40%) on 30 September 2024. Over the past year, it has increased by +$200.00 (+0.01%). KRBP TTM D&A is now -0.40% below its all-time high of $2.23 million, reached on 30 June 2024.KRBP TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KRBP Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +32.7% | -1.6% | +0.0% |
| 3 y3 years | +1010.5% | +321.4% | +435.9% |
| 5 y5 years | +2645.5% | +2566.7% | +3386.8% |
KRBP Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1010.5% | -1.6% | +321.4% | -0.4% | +435.9% |
| 5 y | 5 years | at high | +2645.5% | -1.6% | +2566.7% | -0.4% | +3386.8% |
| alltime | all time | at high | +2645.5% | -1.6% | +2566.7% | -0.4% | >+9999.0% |
Kiromic BioPharma Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $552.00 K(-0.9%) | $2.22 M(-0.4%) |
| June 2024 | - | $557.00 K(0.0%) | $2.23 M(+0.4%) |
| Mar 2024 | - | $557.00 K(+0.3%) | $2.22 M(+0.0%) |
| Dec 2023 | $2.22 M(+32.7%) | $555.10 K(-1.1%) | $2.22 M(+0.0%) |
| Sept 2023 | - | $561.00 K(+2.2%) | $2.22 M(+1.1%) |
| June 2023 | - | $549.00 K(-1.3%) | $2.20 M(+7.3%) |
| Mar 2023 | - | $556.00 K(+0.2%) | $2.05 M(+22.3%) |
| Dec 2022 | $1.67 M(+256.2%) | $554.90 K(+3.4%) | $1.67 M(+33.3%) |
| Sept 2022 | - | $536.60 K(+34.5%) | $1.25 M(+47.8%) |
| June 2022 | - | $399.10 K(+118.3%) | $849.30 K(+52.5%) |
| Mar 2022 | - | $182.80 K(+34.0%) | $557.00 K(+18.6%) |
| Dec 2021 | $469.80 K | $136.40 K(+4.1%) | $469.80 K(+13.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $131.00 K(+22.7%) | $414.50 K(+24.1%) |
| June 2021 | - | $106.80 K(+11.7%) | $333.90 K(+27.5%) |
| Mar 2021 | - | $95.60 K(+17.9%) | $261.80 K(+30.9%) |
| Dec 2020 | $200.00 K(+128.6%) | $81.10 K(+60.9%) | $200.00 K(+40.2%) |
| Sept 2020 | - | $50.40 K(+45.2%) | $142.70 K(+26.3%) |
| June 2020 | - | $34.70 K(+2.7%) | $113.00 K(+13.6%) |
| Mar 2020 | - | $33.80 K(+42.0%) | $99.50 K(+13.7%) |
| Dec 2019 | $87.50 K(+8.2%) | $23.80 K(+15.0%) | $87.50 K(+37.4%) |
| Sept 2019 | - | $20.70 K(-2.4%) | $63.70 K(+48.1%) |
| June 2019 | - | $21.20 K(-2.8%) | $43.00 K(+97.2%) |
| Mar 2019 | - | $21.80 K | $21.80 K |
| Dec 2018 | $80.90 K | - | - |
FAQ
- What is Kiromic BioPharma annual depreciation & amortization?
- What is the all time high annual D&A for Kiromic BioPharma?
- What is Kiromic BioPharma annual D&A year-on-year change?
- What is Kiromic BioPharma quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Kiromic BioPharma?
- What is Kiromic BioPharma quarterly D&A year-on-year change?
- What is Kiromic BioPharma TTM depreciation & amortization?
- What is the all time high TTM D&A for Kiromic BioPharma?
- What is Kiromic BioPharma TTM D&A year-on-year change?
What is Kiromic BioPharma annual depreciation & amortization?
The current annual D&A of KRBP is $2.22 M
What is the all time high annual D&A for Kiromic BioPharma?
Kiromic BioPharma all-time high annual depreciation & amortization is $2.22 M
What is Kiromic BioPharma annual D&A year-on-year change?
Over the past year, KRBP annual depreciation & amortization has changed by +$547.70 K (+32.73%)
What is Kiromic BioPharma quarterly depreciation & amortization?
The current quarterly D&A of KRBP is $552.00 K
What is the all time high quarterly D&A for Kiromic BioPharma?
Kiromic BioPharma all-time high quarterly depreciation & amortization is $561.00 K
What is Kiromic BioPharma quarterly D&A year-on-year change?
Over the past year, KRBP quarterly depreciation & amortization has changed by -$9000.00 (-1.60%)
What is Kiromic BioPharma TTM depreciation & amortization?
The current TTM D&A of KRBP is $2.22 M
What is the all time high TTM D&A for Kiromic BioPharma?
Kiromic BioPharma all-time high TTM depreciation & amortization is $2.23 M
What is Kiromic BioPharma TTM D&A year-on-year change?
Over the past year, KRBP TTM depreciation & amortization has changed by +$200.00 (+0.01%)